The patients’ own corneal cells were cultured and used to reduce corneal cloudiness from the disease, The North East England Stem Cell Institute, Newcastle, England, reported in a release Thursday.
Limbal Stem Cell Deficiency, LSCD, requires long-term, costly treatment with frequent hospital admissions. The advance of corneal stem cells may alleviate much of that and aid people with other cornea problems, said Dr. Francisco Figueiredo, a researcher at the institute.
“Corneal cloudiness has been estimated to cause blindness in 8 million people worldwide each year,” he said. “A large number of ocular surface diseases, both acquired and congenital, share features of partial or complete LSCD.”